Mutual Fund Ownership
Ownership as on: Fri, 29 Mar, 2024

UTI S&P BSE Low Volatility Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)15.90
% of AUM5.10%

Motilal Oswal S&P BSE Low Volatility Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)2.08
% of AUM5.03%

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)10.00
% of AUM3.78%

Aditya Birla Sun Life MNC Fund Growth

NA
Equity
Amount Invested (Cr.)117.79
% of AUM3.32%

Quant Large and Mid Cap Fund Growth

5/5
Equity
Amount Invested (Cr.)49.13
% of AUM2.61%

FAQs about Glaxosmithkline Pharmaceuticals share price

Glaxosmithkline Pharmaceuticals is trading at 1939.00 as on Thu Mar 28 2024 09:59:50. This is 3.05% upper as compared to its previous closing price of 1881.70.

The market capitalization of Glaxosmithkline Pharmaceuticals is 32848.60 Cr as on Thu Mar 28 2024 09:59:50.

The average broker rating on Glaxosmithkline Pharmaceuticals is Hold. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Glaxosmithkline Pharmaceuticals is 2649.95 whereas the 52 wk low is 1228.00

Glaxosmithkline Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 60.78
  • Sector P/E: 31.31
  • Dividend Yield: 1.64%
  • D/E ratio: -

Glaxosmithkline Pharmaceuticals reported a net profit of 610.69 Cr in 2023.

Recommended For You
Images
Trending Stocks
1,643.05+61.85(3.91%)
7,240.35+217.15(3.09%)
1,048.30-5.30 (-0.50%)
2,976.80-11.05 (-0.37%)